Home › NDC Lookup › Ingredients › Witch Hazel › 00904-6829-60
Major Medi-Pads WITCH HAZEL 50 g/100g Cloth, 100 packets — NDC 00904-6829-60 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Major Medi-Pads WITCH HAZEL 50 g/100g Cloth, 100 packets — NDC 0904-6829-60 (Billing 00904-6829-60)

by Major Pharmaceuticals · 100 PACKET in 1 PACKAGE / 2.9 g in 1 PACKET

This is a package of 100 packets of Major Medi-Pads WITCH HAZEL 50 g/100g Cloth from Major Pharmaceuticals, marketed since Jan 2019 and currently FDA-listed; retail pharmacies pay about $0.0435 per packet (NADAC). It is this product's only package size.

NDC 00904-6829-60
🏷️ FDA NDC (as labeled) 0904-6829-60 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0904-6829-60
Product NDC 0904-6829
11-digit billing NDC 00904682960
NCPDP billing unit EA — each (per item)
RxCUI 844379
UNII 101I4J0U34
Application # M016
SPL Set ID d2a314a2-98ab-4ac0-9e90-1a8c1303958f
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-01-25
Route TOPICAL
Dosage form CLOTH
Substance WITCH HAZEL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90970035004300
GPI class Medi-Pads
GCN Seq No 066102
GCN 28286
HICL code 021836
Ingredient (HICL) Witch Hazel
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3D
Therapeutic class — specific (HIC3) Hemorrhoidal Preparations
AHFS code 84:12.00.00
AHFS class Astringents (84:12)
FDB label name MEDI-PADS 50%
FDB brand name Medi-Pads
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 066102
  • GCN: 28286
  • GPI-14 (Medi-Span): 90970035004300
  • HICL (First Databank): 021836
  • AHFS class code: 84:12.00.00
  • RxCUI (RxNorm): 844379
Why two NDCs? The FDA registers this code as 0904-6829-60 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00904-6829-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name MEDI-PADS 50% Ingredient Witch Hazel
🧪 What is this product?

Major Medi-Pads Witch Hazel is a cloth pad saturated with witch hazel extract, applied topically to the skin. Witch hazel is commonly used as an astringent, meaning it may help tighten skin and reduce minor irritation. This product is marketed as an over-the-counter drug under the FDA's monograph system for this class of products, rather than as an individually approved application.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.044 $4.35 / 100 packets
Medicaid paysCMS SDUD · 12 mo $0.0976 $9.76 / 100 packets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Feb 2024 Apr 2026 Sep 2026 $0.045 $0.033
▲ Up 27% over the last 16 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00904-6829-60 You're viewing this Main listing 100 PACKET in 1 PACKAGE / 2.9 g in 1 PACKET 2019-01-25 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Major Medi-Pads 50 g/100gthis 00904-6829-60 Major 100 packets $0.044 — Availability likely —
Medicated Hemorrhoidal Pads 500 mg/mL 70000-0364-01 Cardinal 1 jar $0.044 — Availability likely —
QC Medicated Cooling 500 mg 83324-0311-01 Chain 1 jar $0.044 — Availability likely —
Pre-moistened Medicated Wipes, Pre-moistened Medicated Wipes Witch Hazel 50%/Hemorrhoidal Astringent, Walgreens Pre-moistened Medicated Wipes, Walgreens Pre-moistened Medicated Wipes Witch Hazel 50%/Hemorrhoidal Astringent 50 mg/100mg 00363-1740-48 Walgreens 48 patches — — FDA listed —
Preparation H Medicated Wipes 5 g 00573-0556-07 Haleon 10 packets — — FDA listed —
Preparation H Medicated Wipes 5 g 00573-0557-01 Haleon 48 cloths — — FDA listed —
Preparation H Totables Irritation Relief Wipes 5 g 00573-0558-07 Haleon 10 packets — — FDA listed —
Tucks Medicated Cooling Pads 500 mg/mL 10157-2103-01 Blistex 1 jar — — FDA listed —
up and up medicated wipes manixim strength .5 g/g 11673-0404-48 Target 48 applicators — — FDA listed —
medicated pads 50 mg/100mg 11673-0614-10 TARGET 100 patches — — FDA listed —
Signature Care Medicated Wipes Hemorrhoidal Wipes with Witch Hazel .5 mg/mL 21130-0800-48 Better 252 ml — — FDA listed —
Signature Care Medicated Cooling 500 mg 21130-0928-00 Better 100 cloths — — FDA listed —
Kroger Medicated Wipes Hemorrhoidal Wipe With Witch Hazel And Aloe .5 g/g 30142-0791-71 The 252 g — — FDA listed —
hemorrhoidal pads 500 mg/1000mg 41250-0868-10 Meijer 100 patches — — FDA listed —
medicated wipes 500 mg/1000mg 41250-0988-48 Meijer 48 patches — — FDA listed —
Maximum Strength Hemorrhoidal Pads 500 mg 49035-0465-10 Walmart, 100 cloths — — FDA listed —
Equate Hemorrhoidal Medicated Wipes .5 mg/mL 49035-0793-41 Walmart 252 ml — — FDA listed —
AER Pre-moistened Witch Hazel Pad 500 mg/mL 50289-3250-01 Birchwood 40 applicators — — FDA listed —
AER Traveler Towelette .5 g 50289-4200-01 Birchwood 50 packets — — FDA listed —
B-SURE Traveler Towelette .5 g/g 50289-9250-01 Birchwood 4 g — — FDA listed —
Good Sense Medicated 500 mg 50804-0047-60 Geiss, 100 cloths — — FDA listed —
GOODSENSE Maximum Strength Medicated 50 g/100g 50804-0211-48 GEISS, 48 packets — — FDA listed —
Perineal Cooling Liners 500 mg/g 51316-0716-00 CVS 24 patches — — FDA listed —
TN Dickinsons Witch Hazel Hemorrhoidal Pads 1.2 g 52651-0003-01 Dickinson 1 jar — — FDA listed —
T.N. Dickinsons Witch Hazel Medicated Cooling Pads Hemorrhoidal Relief .034 g 52651-0010-01 Dickinson 1 jar — — FDA listed —
The Pharma-C Company Medicated Hemorrhoidal Pads 500 mg/mL 55239-0359-00 Kleen 100 patches — — FDA listed —
Medicated Wipes Hemorroidal Wipes With Witch Hazel 500 mg/mL 55319-0402-00 FAMILY 48 patches — — Discontinued —
FAMILY Wellness MEDICATED HEMORRHOIDAL WIPES 50 g/100mL 55319-0774-01 Family 1 pouch — — FDA listed —
Rexall Medicated WipesHemorrhoidal wipe Hemorrhoidal wipes with witch hazel 129 g/258g 55910-0105-48 Old 258 g — — FDA listed —
Witch Hazel 50 g/1001 56194-0550-01 Giant 48 cloths — — FDA listed —
Geri Care Medicated Pads 50 mg/mL 57896-0115-01 Geri-Care 100 patches — — FDA listed —
Medicated Wipes Hemorrhoidal Wipes with Witch Hazel .5 g/g 59779-0607-10 CVS 48 applicators — — FDA listed —
CVS Health Medicated 500 mg 59779-0747-01 CVS 1 jar — — FDA listed —
Meicated Wipe 50 g/100g 64709-0120-01 Diamond 195.09 g — — FDA listed —
Dr Talbots Cooling Perineal Pad .5 g/g 70797-0104-01 Talbot's 120 g — — FDA listed —
Dr Butlers Hemorrhoid 50 g/100g 70942-0100-48 Beyond 3 g — — FDA listed —
Hemorrhoidal Hygiene pads 50 g/100mL 71399-0110-01 Akron 175 ml — — FDA listed —
Flushable Hemorrhoidal Medicated Wipes Maximum Strength .5 g 72288-0923-01 Amazon.com 48 cloths — — FDA listed —
frida mom Perineal Cooling Pad Liners .5 g 72705-0100-01 Fridababy, 24 cloths — — FDA listed —
Perineal Cooling Pad Liners 50 g/100g 72705-0420-01 Fridababy, 100 g — — FDA listed —
Medicated Wipes Hemorroidal Wipes With Witch Hazel 500 mg/mL 72932-0009-00 Wuhan 48 patches — — FDA listed —
Medicated Multipurpose Wipes 50 mg/100mg 78691-0050-15 QUEST 15 patches — — FDA listed —
Soothing Hemorrhoidal Wipes 50 Witch Hazel 500 mg/mL 82637-0059-01 The 30 patches — — FDA listed —
Pura 50 mg 84217-0050-48 Mypura.com 48 patches — — FDA listed —
Norms Medicated Wipes .5 g/g 85996-0001-01 Totally 1 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Jan 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII V5VD430YW9
    A plant-derived substance from the aloe vera leaf. Used in medicines as a natural flavor, skin-soothing agent in topical products, and sometimes as a mild laxative ingredient in oral formulations.
  • UNII 2968PHW8QP
    A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
  • UNII Z17H97EA6Y
    A plant-derived mild cleanser made from natural sugars and oils. It acts as an emulsifier and surfactant to help mix water and oil-based ingredients together in the medicine.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII 1VPU26JZZ4
    Potassium sorbate is a salt derived from sorbic acid, a naturally occurring preservative. It prevents growth of mold, yeast, and some bacteria, extending the medicine's shelf life.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII OJ245FE5EU
    Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesWater, Alcohol, Glycerin, Phenoxyethanol, Aloe, Decyl Glucoside, Potassium Sorbate, Propylene Glycol, Sodium Benzoate, Citric Acid

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMajor Pharmaceuticals
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code00904
First marketedJan 2019
Product typeHuman Otc Drug
Portfolio630 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 23 words ▾

Uses helps relieve the local itching and discomfort associated with hemorrhoids temporary relief of irritation and burning. aids in protecting irritated anorectal areas.

⏱️ Dosage and Administration 63 words ▾

Directions adult: Cleanse the area by gently wiping, patting or blotting. If necessary, repeat until all matter is removed from the area. apply externally to the affected area up to 6 times daily or after each bowel movement. After application, discard pad and wash hands. children under 12 years of age:Consult a doctor Dispose of pad in trash after use. Do not flush

⚠️ Warnings 85 words ▾

Warnings For external use only. When using this product do not exceed the recommended daily dosage unless directed by a doctor do not put this product into the rectum by using fingers or any mechanical device or applicator. Stop use and ask a doctor if bleeding occurs condition worsens or does not improve within 7 days Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.(1-800-222-1222) If pregnant or breast-feeding ask a health professional before use.

🤰 Pregnancy 10 words ▾

If pregnant or breast-feeding ask a health professional before use.

📦 Storage and Handling 8 words ▾

Other information store at room temperature 15-30°C (59-86°F)

🧪 Active Ingredient 5 words ▾

Active Ingredient Witch hazel 50%

🧪 Inactive Ingredients 17 words ▾

Inactive Ingredients Water, Alcohol, Glycerin, Phenoxyethanol, Aloe, Decyl Glucoside, Potassium Sorbate, Propylene Glycol, Sodium Benzoate, Citric Acid

🎯 Purpose 2 words ▾

Purpose Astringent

📄 When Using This Product 33 words ▾

When using this product do not exceed the recommended daily dosage unless directed by a doctor do not put this product into the rectum by using fingers or any mechanical device or applicator.

📄 Stop Use and Ask a Doctor If 18 words ▾

Stop use and ask a doctor if bleeding occurs condition worsens or does not improve within 7 days

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.(1-800-222-1222)

📄 Questions or Comments 5 words ▾

Questions or Comments? (800) 616-2471

📄 Package Label / Principal Display Panel 55 words ▾

Principal Display Panel NDC 0904-6829-60 MAJOR MEDI-PADS Hemorrhoidal Pads with Witch Hazel Cools, soothes and helps relieve local discomfort associated with hemorrhoids Convenient to use 100 pads 3.0 in dia (7.5 cm dia) Compare to Tucks active ingredient* * This product is not manufactured or distrbiuted by McNEIL-PPC, Inc., owner of registered trademark Trucks Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
564
Units reimbursed last 4 qtrs
56.5K
Gross reimbursed last 4 qtrs
$5.5K
Avg / prescription
$9.78
Avg / unit
$0.0976
Latest quarter Q1 2026
62Rx
Medicaid pays / ea
$0.0976
gross reimbursed
vs
NADAC / ea
$0.0435
acquisition cost
=
Spread
+$0.0541
+124% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
94% MCO
Fee-for-service · 34 Rx Managed care · 530 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 8,966 units · 156 per 100k residents MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 9,540 units · 139 per 100k residents IN Ohio: 31,338 units · 266 per 100k residents OH Pennsylvania: 1,500 units · 11.6 per 100k residents PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 4,100 units · 10.5 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: 1,101 units · 101 per 100k residents RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
10.5266
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Ohio 266 /100k
2 Minnesota 156 /100k
3 Indiana 139 /100k
4 Rhode Island 101 /100k
5 Pennsylvania 11.6 /100k
6 California 10.5 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Major Medi-Pads (this brand).

Top reported reactions

Erythema10
Skin Burning Sensation10
Nausea7
Dry Skin6
Fatigue6
Headache6
Acne5

Age at onset

Child1
Adult4
Elderly1

Reporter sex

87 reports
Male · 35%
Female · 65%

Serious outcomes

Hospitalization28
Disabling5
Life-threatening4
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 8 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.